Back to Search

MINDI COHEN, DO

DO

Family Medicine Physician

NPI: 1104811553IndividualAccepts Medicare

Specialties, Licenses & Credentials

Family Medicine PhysicianPrimary

Family Medicine

Code: 207Q00000X

H0046438(MD)

CMS Specialties

PrimaryFAMILY PRACTICE

Education

PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE

Class of 1990

Clinical Trials (1)

1
Linked Trials
0
Recruiting
1
With Results

Intrathecal Morphine Versus Epidural Extended Release Morphine for Pediatric Patients Undergoing Spinal Fusion

NCT00880607COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (20)

FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma.
PMID 18586926·Oncologist·2008
8-other
FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer.
PMID 17405901·Oncologist·2007
4-observational
Food and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme.
PMID 16203762·Clin Cancer Res·2005
4-observational
FDA drug approval summary: erlotinib (Tarceva) tablets.
PMID 16079312·Oncologist·2005
4-observational
U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
PMID 15671523·Clin Cancer Res·2005
3-trial
United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets.
PMID 14977817·Clin Cancer Res·2004
8-other
FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets.
PMID 12897327·Oncologist·2003
3-trial
U.S. Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acid.
PMID 12401901·Oncologist·2002
8-other
Gleevec for the treatment of chronic myelogenous leukemia: US. Food and Drug Administration regulatory mechanisms, accelerated approval, and orphan drug status.
PMID 12401900·Oncologist·2002
8-other
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
PMID 12006504·Clin Cancer Res·2002
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
15825 SHADY GROVE RD, STE 140
ROCKVILLE, MD 20850

Quick Facts

NPI
1104811553
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
36
Clinical Trials
1
Publications
20

Are you this provider?

Claim Your Profile